1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in Japan, July 2016

Pharmaceutical Analysis & Statistics in Japan, July 2016

1-30 of about 800 reports

Purchase Reports From Reputable Market Research Publishers

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • € 3 996
  • Industry report
  • May 2016
  • by GBI Research

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Summary Non-Small Cell Lung Cancer (NSCLC) is ...

  • Industries : Therapy, Pharmaceutical
  • Countries : Asia, India, World, Australia, Japan, South Korea, China
Global Ostomy and Incontinence Product Industry

Global Ostomy and Incontinence Product Industry

  • € 3 960
  • Industry report
  • June 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Ostomy and Incontinence Products in US$ Thousand by the following Product Segments: Incontinence Products (Disposable Adult Diapers, Disposable Adult Shields, ...

  • Industries : OTC, Medical Supply
  • Countries : Japan, World, Europe, Asia, Canada
Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2022

Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2022

  • € 3 960
  • Industry report
  • May 2016
  • by Delve Insight

The Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2022 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: ...

  • Industries : Therapy, Chronic Disease
  • Countries : World, United States, Japan, United Kingdom
Venous Thromboembolism-Market Insights & Drugs SalesForecast (VTE) -2020

Venous Thromboembolism-Market Insights & Drugs SalesForecast (VTE) -2020

  • € 3 960
  • Industry report
  • May 2016
  • by Delve Insight

DelveInsight Report “Venous Thromboembolism-Market Insights & Drugs Sales Forecast (VTE) -2020” provides an overview of the Venous Thromboembolism indication. The Report majorly emphasize on the global ...

  • Industries : Therapy
  • Countries : United States, France, Germany, Italy, Spain, United Kingdom, Japan
Japan Clinical Chemistry and Immunodiagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

Japan Clinical Chemistry and Immunodiagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

  • € 3 920
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $7,600.  DataPack (test volumes, sales forecasts, supplier shares) $4,900. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the Japanese clinical ...

  • Industries : Therapy
  • Countries : Japan
Japan Clinical Chemistry and Immunodiagnostic Markets: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Japan Clinical Chemistry and Immunodiagnostic Markets: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • € 3 920
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $7,600.  DataPack (test volumes, sales forecasts, supplier shares) $4,900. VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the Japanese ...

  • Industries : Therapy
  • Countries : Japan
Japan Market Report for Anti-Adhesion Products - MedCore

Japan Market Report for Anti-Adhesion Products - MedCore

  • € 3 196
  • Industry report
  • June 2016
  • by iData Research, Inc.

The anti-adhesion market, also referred to as the adhesion prevention market, includes products aimed atminimizing surgical adhesions. Surgical adhesions are fibrous bands that form between tissues and ...

  • Industries : Therapy
  • Countries : Japan
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H1 2016

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H1 2016

  • € 2 800
  • Company report
  • June 2016
  • by Global Markets Direct

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Recepto ...

  • Industries : Pharmaceutical, Pathology
  • Countries : Japan, World
C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016

C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016

  • € 2 800
  • Company report
  • May 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - ...

  • Industries : Biological Therapy, Therapy, Cancer, Pharmaceutical, Pathology
  • Countries : Japan, World
Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016

Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016

  • € 2 800
  • Company report
  • April 2016
  • by Global Markets Direct

Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) ...

  • Industries : Chemical, In Vitro Diagnostics, Pharmaceutical, Therapy
  • Countries : Japan
Global Epilepsy Drugs Market 2016-2020

Global Epilepsy Drugs Market 2016-2020

  • € 2 000
  • Industry report
  • July 2016
  • by Infiniti Research Limited

About the Epilepsy Drugs Market Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by ...

  • Industries : Mental Health, General Medicine and Specialty Medicine, Pathology, Healthcare, Therapy
  • Countries : World, Europe, Japan
Infusion Systems Market in Japan 2016-2020

Infusion Systems Market in Japan 2016-2020

  • € 2 000
  • Industry report
  • June 2016
  • by Infiniti Research Limited

About the Infusion Systems Market in Japan An infusion system is an external pump used to deliver regulated amounts of drugs and nutrients to individuals through intravenous, epidural or enteral, and subcutaneous ...

  • Industries : Therapy
  • Countries : Japan
Encephalitis Global Clinical Trials Review, H1, 2016

Encephalitis Global Clinical Trials Review, H1, 2016

  • € 2 000
  • Industry report
  • April 2016
  • by Global Data

Encephalitis Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Encephalitis Global Clinical Trials Review, H1, 2016" provides an overview of Encephalitis clinical trials ...

  • Industries : Therapy, Pharmaceutical, Biopharmaceutical
  • Countries : World, Japan
Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016

Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016

  • € 1 600
  • Company report
  • June 2016
  • by Global Markets Direct

Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016’, provides an overview ...

  • Industries : Chronic Disease, Pathology
  • Countries : World, United States, Japan
Rhino-Conjunctivitis - Pipeline Review, H1 2016

Rhino-Conjunctivitis - Pipeline Review, H1 2016

  • € 1 600
  • Industry report
  • June 2016
  • by Global Markets Direct

Rhino-Conjunctivitis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Rhino-Conjunctivitis - Pipeline Review, H1 2016’, provides an overview of the Rhino-Conjunctivitis pipeline landscape. ...

  • Industries : Pathology, Therapy, Chronic Disease, Pharmaceutical, Healthcare, Biopharmaceutical
  • Countries : World, Japan
Japan Therapeutic Drug Monitoring (TDM) Market: Emerging Opportunities and Growth Strategies for Suppliers

Japan Therapeutic Drug Monitoring (TDM) Market: Emerging Opportunities and Growth Strategies for Suppliers

  • € 1 360
  • Industry report
  • July 2016
  • by Venture Planning Group

This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales ...

  • Industries : Therapy
  • Countries : Japan
Japan Endocrine Function Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

Japan Endocrine Function Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • € 1 360
  • Industry report
  • July 2016
  • by Venture Planning Group

This new 269-page report from VPGMarketResearch.com provides a comprehensive analysis in the Japanese endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts ...

  • Industries : Therapy
  • Countries : Japan
Japan Drugs of Abuse Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

Japan Drugs of Abuse Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • € 1 360
  • Industry report
  • July 2016
  • by Venture Planning Group

This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Therapy
  • Countries : Japan
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Japan

IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Japan

  • € 1 360
  • Industry report
  • June 2016
  • by IMS Health

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of ...

  • Industries : Therapy
  • Countries : Japan
Japan Therapeutic Drug Monitoring (TDM): Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

Japan Therapeutic Drug Monitoring (TDM): Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

  • € 1 360
  • Industry report
  • June 2016
  • by Venture Planning Group

This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales ...

  • Industries : Therapy
  • Countries : Japan
Japan Endocrine Function Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

Japan Endocrine Function Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

  • € 1 360
  • Industry report
  • June 2016
  • by Venture Planning Group

This new 269-page report from VPGMarketResearch.com provides a comprehensive analysis in the Japanese endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts ...

  • Industries : Therapy
  • Countries : Japan
Japan Drugs of Abuse: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

Japan Drugs of Abuse: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

  • € 1 360
  • Industry report
  • June 2016
  • by Venture Planning Group

This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Therapy
  • Countries : Japan
XOMA Corporation - Product Pipeline Review - 2016

XOMA Corporation - Product Pipeline Review - 2016

  • € 1 200
  • Company report
  • June 2016
  • by Global Markets Direct

XOMA Corporation - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘XOMA Corporation - Product Pipeline Review - 2016’, provides an overview of the XOMA Corporation’s pharmaceutical ...

  • Industries : Research and Development, Therapy, Pathology
  • Countries : United States, World, Japan
Cancer Drug News 18 JULY 2016

Cancer Drug News 18 JULY 2016

  • € 988
  • Industry report
  • July 2016
  • by Espicom Business Intelligence

Industry Trend Analysis - Precision Medicine Importance Increases Industry Brief - Boehringer/Lilly Enter Trial Collaboration Industry Brief - Revlimid Approved For Relapsed Mantle Cell Lymphoma Industry ...

  • Industries : Therapy
  • Countries : Japan
Cancer Drug News 04 JULY 2016

Cancer Drug News 04 JULY 2016

  • € 988
  • Industry report
  • July 2016
  • by Espicom Business Intelligence

Industry Trend Analysis - EU Filing Will Not Distract From Neratinib US Issues Industry Brief - FDA Grants Fast Track Designation To ONT-380 For Advanced HER2+ MBC Industry Brief - CHMP Issues Negative ...

  • Industries : Therapy
  • Countries : Europe, Japan
Japan Pharmaceuticals and Healthcare Report Q3 2016

Japan Pharmaceuticals and Healthcare Report Q3 2016

  • € 985
  • Industry report
  • May 2016
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: There will be opportunities for haemophilia products within the Japan pharmaceutical market.The country has the third largest population of haemophilia patients ...

  • Industries : Pharmaceutical
  • Countries : Japan
Japan Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

Japan Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

  • € 960
  • Industry report
  • May 2016
  • by International Market Analysis Research and Consult

Japan represents the world’s eighth biggest market for generic drugs in terms of value. Generic drugs, however, have traditionally enjoyed a relatively lower penetration in Japan compared to other developed ...

  • Industries : Generic Drug
  • Countries : Japan
Incontinence in Japan

Incontinence in Japan

  • € 800
  • Industry report
  • April 2016
  • by Euromonitor International

Incontinence in Japan recorded 7% current value growth in 2015 to reach ¥190 billion, due to the increasing ageing of the Japanese population, which shows no sign of stopping. The number of the Japanese ...

  • Industries : OTC
  • Countries : Japan
 Spirulina Extract Market Outlook - Market size, segmentation, market share and competitive landscape (2016-2021)15-2020)

Spirulina Extract Market Outlook - Market size, segmentation, market share and competitive landscape (2016-2021)15-2020)

  • € 640
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Global Extract Spirulina market is worth XX.XX billion USD and is expected to grow at a CAGR of XX.XX % in next five years. Major companies/firms involved in this market includes: Sensient Technologies ...

  • Industries : OTC
  • Countries : World, Europe, Japan
Pharmaceuticals in Japan: ISIC 2423

Pharmaceuticals in Japan: ISIC 2423

  • € 530
  • Industry report
  • May 2016
  • by Euromonitor International

Euromonitor International’s Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals market ...

  • Industries : Pharmaceutical
  • Countries : Japan

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.